Literature DB >> 12406996

Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients.

Maurice M A L Pelsers1, Alireza Morovat, Graeme J M Alexander, Wim T Hermens, Andrew K Trull, Jan F C Glatz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406996

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  19 in total

1.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

2.  Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.

Authors:  Constantine J Karvellas; Jaime L Speiser; Mélanie Tremblay; William M Lee; Christopher F Rose
Journal:  Hepatology       Date:  2017-01-19       Impact factor: 17.425

3.  Serum FABP1 Levels Correlate Positively with Obesity in Chinese Patients After Laparoscopic Sleeve Gastrectomy: a 12-Month Follow-up Study.

Authors:  Hui You; Xin Wen; Cuiling Zhu; Ming Chen; Liting Dong; Yanli Zhu; Liu Yang; Le Bu; Manna Zhang; Donglei Zhou; Liesheng Lu; Lei Du; Ziwei Lin; Shen Qu
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

4.  Liver fatty acid-binding protein as a diagnostic marker for non-alcoholic fatty liver disease.

Authors:  Erdem Akbal; Erdem Koçak; Ömer Akyürek; Seyfettin Köklü; Hikmetullah Batgi; Mehmet Şenes
Journal:  Wien Klin Wochenschr       Date:  2014-12-02       Impact factor: 1.704

5.  Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.

Authors:  Rachel J Church; Gerd A Kullak-Ublick; Jiri Aubrecht; Herbert L Bonkovsky; Naga Chalasani; Robert J Fontana; Jens C Goepfert; Frances Hackman; Nicholas M P King; Simon Kirby; Patrick Kirby; John Marcinak; Sif Ormarsdottir; Shelli J Schomaker; Ina Schuppe-Koistinen; Francis Wolenski; Nadir Arber; Michael Merz; John-Michael Sauer; Raul J Andrade; Florian van Bömmel; Thierry Poynard; Paul B Watkins
Journal:  Hepatology       Date:  2018-06-27       Impact factor: 17.425

6.  The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations.

Authors:  Hafidh A Al-Hadi; Brent William; Keith A Fox
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

7.  Localization, function and regulation of the two intestinal fatty acid-binding protein types.

Authors:  Emile Levy; Daniel Ménard; Edgard Delvin; Alain Montoudis; Jean-François Beaulieu; Geneviève Mailhot; Nadia Dubé; Daniel Sinnett; Ernest Seidman; Moise Bendayan
Journal:  Histochem Cell Biol       Date:  2009-06-05       Impact factor: 4.304

8.  Salivary and serum biomarkers for the study of side effects of aripiprazole coprescribed with mirtazapine in rats.

Authors:  Maria Bogdan; Isabela Silosi; Petra Surlin; Andrei Adrian Tica; Oana Sorina Tica; Tudor-Adrian Balseanu; Anne-Marie Rauten; Adrian Camen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 9.  Metabolic functions of FABPs--mechanisms and therapeutic implications.

Authors:  Gökhan S Hotamisligil; David A Bernlohr
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

10.  The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitis.

Authors:  Ozlem Ozer Cakir; Aysun Toker; Huseyin Ataseven; Ali Demir; Hakki Polat
Journal:  J Clin Diagn Res       Date:  2017-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.